Hosp. Da Luz Lisboa

Lisbon 1500 650

0 studies enrolling now · 2 studies all time

What they study most

Lupus Erythematosus, Systemic, Prostatic Neoplasms

Studies at this site

• A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer — Running, not enrolling
• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early